CANCER RESEARCH AND TREATMENT INSTITUTE (EIN 461550312) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

LARRY MACKAY

Phone

8002843971

Tax Period

2023-10-01 to 2024-09-30

CANCER RESEARCH AND TREATMENT INSTITUTE, founded in 2012, is a micro nonprofit in the Diseases & Disorders sector that reported $62K in total revenue in fiscal year 2023.

Mission

It provides information on cancer research and treatment. The Organization ships medical equipment, supplies and aid to hospitals and clinics that treat people with cancer and give research grants.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $61,882

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $61,882

Expense Breakdown

Grants Paid $51,524

Salaries & Benefits $0

Fundraising Expenses $792

Program Expenses $65,239

Other Expenses $16,077

TOTAL EXPENSES $67,601

Year-over-Year Comparison

	2023	2022	Change
Revenue	$61,882	$63,240	0.0%
Expenses	$67,601	$62,075	+0.1%
Net Income	$-5,719	$1,165	-5.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LARRY MACKAY	PRESIDENT	005.00	Officer Director	$0	$0	$0
DORETH BARELA	SECRETARY / TREASURER	N/A	Officer Director	$0	$0	$0
MICHAEL HAYNES	DIRECTOR	N/A	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$61,882	$67,601	$16,924	$-5,719
2023	$63,240	$62,075	$20,369	$1,165
2022	$83,184	$87,860	$19,804	$-4,676
2021	$83,080	$78,315	$24,480	$4,765
2020	$89,622	$92,469	$19,715	$-2,847
2019	$129,293	$126,490	$22,563	$2,803
2018	$231,676	$220,349	$19,760	$11,327

CANCER RESEARCH AND TREATMENT INSTITUTE